|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to New York Times Health News Archives
New York Times Health News: 09-27-2004
Merck has obtained rights to license an experimental anti-obesity drug that is based on a hormone the body uses to signal that it has eaten enough.
A battle between insurers and drug companies could determine how many medicines will be available to beneficiaries.
The technological marvels of medicine mean that the insured majority are being treated for ailments that went untreated or undetected years ago.
Sometimes it takes one doctor's persistence to help a desperate patient find relief.
Employment researchers are increasingly acknowledging that having sick employees work is not just painful for the employees, but can also hurt the company.
|
|
